Universal screening for all newly diagnosed colorectal cancer patients to identify Lynch syndrome

Universal screening for all newly diagnosed colorectal cancer patients to identify Lynch syndrome - Universal screening to identify Lynch syndrome

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024037

Enrollment

500

Registered

2016-11-01

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Colorectal cancer patients treated at our hospital

Exclusion criteria

Exclusion criteria: Patients under 18 years old Patients whose cancer tissue is not available for MSI analysis and immunostaining

Design outcomes

Primary

Measure	Time frame
Rate of Lynch syndrome patients who meet the Amsterdam criteria and the Bethesda guidelines to all Lynch patients	—

Secondary

Measure	Time frame
Sensitivity of MSI and immunostaining to identify Lynch syndrome	—

Countries

Japan

Contacts

Public ContactKentaro Yamashita

Sapporo Medical Universtiy Department of Gastroeterology and Hepatology

ykentaro@sapmed.ac.jp011-611-2111

Outcome results